Stocks & Investing
Stocks and Investing
Stocks and Investing
Mon, March 27, 2023
[ Mon, Mar 27th 2023
] - WOPRAI
[ Mon, Mar 27th 2023
] - WOPRAI
[ Mon, Mar 27th 2023
] - WOPRAI
[ Mon, Mar 27th 2023
] - WOPRAI
[ Mon, Mar 27th 2023
] - WOPRAI
[ Mon, Mar 27th 2023
] - WOPRAI
[ Mon, Mar 27th 2023
] - WOPRAI
[ Mon, Mar 27th 2023
] - WOPRAI
[ Mon, Mar 27th 2023
] - WOPRAI
[ Mon, Mar 27th 2023
] - WOPRAI
[ Mon, Mar 27th 2023
] - WOPRAI
[ Mon, Mar 27th 2023
] - WOPRAI
[ Mon, Mar 27th 2023
] - WOPRAI
[ Mon, Mar 27th 2023
] - WOPRAI
[ Mon, Mar 27th 2023
] - WOPRAI
[ Mon, Mar 27th 2023
] - WOPRAI
[ Mon, Mar 27th 2023
] - WOPRAI
[ Mon, Mar 27th 2023
] - WOPRAI
[ Mon, Mar 27th 2023
] - WOPRAI
[ Mon, Mar 27th 2023
] - WOPRAI
[ Mon, Mar 27th 2023
] - WOPRAI
[ Mon, Mar 27th 2023
] - WOPRAI
[ Mon, Mar 27th 2023
] - WOPRAI
[ Mon, Mar 27th 2023
] - WOPRAI
[ Mon, Mar 27th 2023
] - WOPRAI
[ Mon, Mar 27th 2023
] - WOPRAI
[ Mon, Mar 27th 2023
] - WOPRAI
[ Mon, Mar 27th 2023
] - WOPRAI
[ Mon, Mar 27th 2023
] - WOPRAI
Floris Van Dijkum Maintained (DOC) at Strong Buy with Decreased Target to $19 on, Mar 27th, 2023
Floris Van Dijkum of Compass Point, Maintained "Healthpeak Properties, Inc." (DOC) at Strong Buy with Decreased Target from $21 to $19 on, Mar 27th, 2023.
Floris has made no other calls on DOC in the last 4 months.
There are 3 other peers that have a rating on DOC. Out of the 3 peers that are also analyzing DOC, 1 agrees with Floris's Rating of Hold. Following is the relevant analyst calls for the last 4 months
- Michael Carroll of "RBC Capital" Maintained at Hold with Decreased Target to $15 on, Tuesday, February 28th, 2023
These are the ratings of the 2 analyists that currently disagree with Floris
- Steve Valiquette of "Barclays" Maintained at Buy with Decreased Target to $18 on, Tuesday, January 17th, 2023
- Todd Thomas of "Keybanc" Upgraded from Hold to Buy and Held Target at $17 on, Wednesday, December 14th, 2022
